ANT BIO PTE. LTD. Official Review: OST Complex and OST Antibodies – From Glycosylation Regulation to Disease Diagnosis and Therapeutic Applications

Literature Information

This review summarizes recent advances in understanding the Oligosaccharyltransferase (OST) complex, its core functions in N‑glycosylation, disease associations, and the applications of OST‑targeted antibodies in basic research, clinical diagnostics, and translational medicine. It integrates structural biology, glycobiology, oncology, immunology, and neurodegenerative disease research.

Research Background

The OST complex is an evolutionarily conserved membrane‑embedded enzyme complex located on the endoplasmic reticulum (ER). It catalyzes the co‑translational and post‑translational transfer of pre‑assembled oligosaccharide chains to asparagine residues of nascent polypeptides, a process known as N‑linked glycosylation. This modification is essential for protein folding, stability, trafficking, and function.

Dysregulation of the OST complex is closely linked to congenital disorders of glycosylation (CDG), cancer progression, viral infection, autoimmune diseases, neurodegeneration, and cardiovascular dysfunction. High‑quality antibodies and research tools targeting OST subunits are therefore critical for mechanistic studies and biomarker development.

Research Logic and Methodology

This review systematically analyzes:

1. The molecular architecture and functional specialization of the mammalian OST complex (STT3A‑ and STT3B‑dependent isoforms).
2. The key role of the DDOST/OST48 subunit in substrate recognition and complex stability.
3. Disease mechanisms driven by OST dysfunction.
4. Development, validation, and clinical applications of OST antibodies.
5. Technical challenges and optimization strategies for OST‑related research.

Key Research Findings

• The OST complex exists in two functionally distinct isoforms: STT3A‑OST mediates co‑translational glycosylation, while STT3B‑OST supports post‑translational modification.
• The OST48 (DDOST) subunit is essential for complex assembly, glycosylation site recognition, and overall enzymatic activity.
• Abnormal expression of OST subunits, especially OST48, is widely observed in liver, gastric, colorectal, and breast cancers and correlates with malignancy and poor prognosis.
• OST antibodies enable reliable detection, quantification, and localization of OST complexes in cells, tissues, and liquid biopsies.
• OST‑dependent glycosylation shapes immune recognition, viral protein maturation, and autoimmune antigen presentation.

Product Empowerment by ANT BIO PTE. LTD.

ANT BIO PTE. LTD. provides a complete portfolio of research tools to support OST and glycosylation research:

• Absin: General buffers, assay kits, protein extraction reagents, and WB/IF/IHC supporting kits.
• Starter: Highly specific monoclonal and polyclonal antibodies against OST subunits (OST48, STT3A, STT3B, etc.).
• UA: Recombinant OST proteins, modified proteins, and glycosylation‑related standards.

These reagents ensure high sensitivity, specificity, and reproducibility in OST‑related experiments, including Western blot, immunoprecipitation, immunofluorescence, ELISA, and functional assays.

Brand Mission

ANT BIO PTE. LTD. is a professional supplier of life science reagents dedicated to accelerating global scientific discovery and medical progress. Our three specialized brands—Absin, Starter, and UA—provide researchers with reliable, consistent, and innovative tools for glycobiology, oncology, immunology, and neurodegenerative disease research.

Related Product List

表格

Brand Promotion

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights